Non-small cell lung cancer staging: proposed revisions to the TNM system

por Schneider, Bryan J.
Publicado 2008

Anti-VEGF therapy as adjuvant therapy: clouds on the horizon?

por Schneider, Bryan P, Sledge, George W
Publicado 2009

Immune Checkpoint Inhibitor-Associated Colitis and Hepatitis

por Reddy, Haritha G., Schneider, Bryan J., Tai, Andrew W.
Publicado 2018

Correction: Immune Checkpoint Inhibitor-Associated Colitis and Hepatitis

por Reddy, Haritha G., Schneider, Bryan J., Tai, Andrew W.
Publicado 2018

Exceptional Response with Immunotherapy in a Patient with Anaplastic Thyroid Cancer

por Kollipara, Revathi, Schneider, Bryan, Radovich, Milan, Babu, Sunil, Kiel, Patrick J.
Publicado 2017

Clinically significant germline pathogenic variants are missed by tumor genomic sequencing

por Stout, Leigh Anne, Hunter, Cynthia, Schroeder, Courtney, Kassem, Nawal, Schneider, Bryan P.
Publicado 2023

Liver injury during durvalumab-based immunotherapy is associated with poorer patient survival: A retrospective analysis

por Swanson, Linnea A., Kassab, Ihab, Tsung, Irene, Schneider, Bryan J., Fontana, Robert J.
Publicado 2022

Functional microRNAs in Alzheimer’s disease and cancer: differential regulation of common mechanisms and pathways

por Holohan, Kelly N., Lahiri, Debomoy K., Schneider, Bryan P., Foroud, Tatiana, Saykin, Andrew J.
Publicado 2013

Identification of germline cancer predisposition variants during clinical ctDNA testing

por Stout, Leigh Anne, Kassem, Nawal, Hunter, Cynthia, Philips, Santosh, Radovich, Milan, Schneider, Bryan P.
Publicado 2021

A large, consistent plasma proteomics data set from prospectively collected breast cancer patient and healthy volunteer samples

por Riley, Catherine P, Zhang, Xiang, Nakshatri, Harikrishna, Schneider, Bryan, Regnier, Fred E, Adamec, Jiri, Buck, Charles
Publicado 2011

Potential roles of microRNAs in regulating long intergenic noncoding RNAs

por Juan, Liran, Wang, Guohua, Radovich, Milan, Schneider, Bryan P, Clare, Susan E, Wang, Yadong, Liu, Yunlong
Publicado 2013

Impact of African ancestry on the relationship between body mass index and survival in an early‐stage breast cancer trial (ECOG‐ACRIN E5103)

por Ballinger, Tarah J., Jiang, Guanglong, Shen, Fei, Miller, Kathy D., Sledge, George W., Schneider, Bryan P.
Publicado 2022

“How is it going to help?”: Exploring Black breast cancer patients’ questions about biomarker testing to predict chemotherapy-induced peripheral neuropathy

por Head, Katharine J., Hayes, Lisa R., Miller, Nadia E., Shakil, Safia, Bales, Casey L., Schneider, Bryan P.
Publicado 2022

Life-Threatening Docetaxel Toxicity in a Patient With Reduced-Function CYP3A Variants: A Case Report

por Powell, Nicholas R., Shugg, Tyler, Ly, Reynold C., Albany, Costantine, Radovich, Milan, Schneider, Bryan P., Skaar, Todd C.
Publicado 2022

Passage number affects differentiation of sensory neurons from human induced pluripotent stem cells

por Cantor, Erica L., Shen, Fei, Jiang, Guanglong, Tan, Zhiyong, Cunningham, Geneva M., Wu, Xi, Philips, Santosh, Schneider, Bryan P.
Publicado 2022

A non-coding GWAS variant impacts anthracycline-induced cardiotoxic phenotypes in human iPSC-derived cardiomyocytes

por Wu, Xi, Shen, Fei, Jiang, Guanglong, Xue, Gloria, Philips, Santosh, Gardner, Laura, Cunningham, Geneva, Bales, Casey, Cantor, Erica, Schneider, Bryan Paul
Publicado 2022

Pilot trial of paclitaxel-trastuzumab adjuvant therapy for early stage breast cancer: a trial of the ECOG-ACRIN cancer research group (E2198)

por Schneider, Bryan P, O'Neill, Anne, Shen, Fei, Sledge, George W, Thor, Ann D, Kahanic, Stephen P, Zander, Paul J, Davidson, Nancy E
Publicado 2015

Quality of Life Following Receipt of Adjuvant Chemotherapy With and Without Bevacizumab in Patients With Lymph Node–Positive and High-Risk Lymph Node–Negative Breast Cancer

por Rosenberg, Shoshana M., O’Neill, Anne, Sepucha, Karen, Miller, Kathy D., Dang, Chau T., Northfelt, Donald W., Sledge, George W., Schneider, Bryan P., Partridge, Ann H.
Publicado 2022

Cellular engagement and interaction in the tumor microenvironment predict non-response to PD-1/PD-L1 inhibitors in metastatic non-small cell lung cancer

por Qin, Angel, Lima, Fatima, Bell, Samantha, Kalemkerian, Gregory P., Schneider, Bryan J., Ramnath, Nithya, Lew, Madelyn, Krishnan, Santhoshi, Mohammed, Shariq, Rao, Arvind, Frankel, Timothy L.
Publicado 2022

A pharmacogenetics study to predict outcome in patients receiving anti-VEGF therapy in age related macular degeneration

por Kitchens, John W, Kassem, Nawal, Wood, William, Stone, Thomas W, Isernhagen, Rick, Wood, Edward, Hancock, Brad A, Radovich, Milan, Waymire, Josh, Li, Lang, Schneider, Bryan P
Publicado 2013